The Strategy: 3Ps
Principle Strategy - UroLogic aims to become a world leading provider of innovative medical equipment for use inside the body. For the smart catheter, UroLogic will develop the IP and license it to the major players in the market.
Product - The company will offer licenses, know-how and technical support to interested parties. Initially this will be directed at indwelling catheters.
Pricing - Infections caused by current indwelling catheters cost the NHS approximately £2 billion annually. If there is a 50% overall reduction in infections, the NHS would potentially save significantly and the number of related deaths. Our catheter pricing will remain competitive to healthcare providers.